ASX - By Stock
|
EBR |
Re:
General Investor Information EBR Systems
|
|
njpet8
|
271 |
92K |
2 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
271
|
92K
|
2
|
|
ASX - By Stock
|
EBR |
Re:
Charting
|
|
njpet8
|
284 |
69K |
5 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
284
|
69K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
Ann: ProstACT SELECT Study of TLX591 rADC Therapy - Positive rPFS
|
|
njpet8
|
187 |
58K |
14 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
187
|
58K
|
14
|
|
ASX - By Stock
|
TLX |
Re:
Ann: ProstACT SELECT Study of TLX591 rADC Therapy - Positive rPFS
|
|
njpet8
|
187 |
58K |
13 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
187
|
58K
|
13
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Clarity strengthens Cu-64 network with new supply agreement
|
|
njpet8
|
50 |
15K |
7 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
50
|
15K
|
7
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Clarity strengthens Cu-64 network with new supply agreement
|
|
njpet8
|
50 |
15K |
4 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
50
|
15K
|
4
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
njpet8
|
1.0K |
463K |
7 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
1.0K
|
463K
|
7
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix has Filed Registration Statement for Proposed US IPO
|
|
njpet8
|
43 |
13K |
6 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
43
|
13K
|
6
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
njpet8
|
1.5K |
589K |
8 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
1.5K
|
589K
|
8
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
njpet8
|
1.0K |
463K |
0 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
1.0K
|
463K
|
0
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
njpet8
|
1.0K |
463K |
5 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
1.0K
|
463K
|
5
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
njpet8
|
1.0K |
463K |
2 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
1.0K
|
463K
|
2
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
njpet8
|
1.0K |
463K |
1 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
1.0K
|
463K
|
1
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
njpet8
|
1.0K |
463K |
4 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
1.0K
|
463K
|
4
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
njpet8
|
1.0K |
463K |
4 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
1.0K
|
463K
|
4
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
njpet8
|
1.0K |
463K |
6 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
1.0K
|
463K
|
6
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Q1 2024 Revenue and Business Update
|
|
njpet8
|
153 |
61K |
3 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
153
|
61K
|
3
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
njpet8
|
209 |
85K |
11 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
209
|
85K
|
11
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
njpet8
|
1.0K |
463K |
15 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
1.0K
|
463K
|
15
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
njpet8
|
1.0K |
463K |
9 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
1.0K
|
463K
|
9
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
njpet8
|
1.0K |
463K |
4 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
1.0K
|
463K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix 2023 Full Year Results and Investor Webcast/Call
|
|
njpet8
|
130 |
44K |
3 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
130
|
44K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix 2023 Full Year Results and Investor Webcast/Call
|
|
njpet8
|
130 |
44K |
2 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
130
|
44K
|
2
|
|
ASX - By Stock
|
EBR |
Re:
General Investor Information EBR Systems
|
|
njpet8
|
271 |
92K |
1 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
271
|
92K
|
1
|
|
ASX - By Stock
|
EBR |
Re:
General Investor Information EBR Systems
|
|
njpet8
|
271 |
92K |
1 |
14/01/24 |
14/01/24 |
ASX - By Stock
|
271
|
92K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: JP Morgan Healthcare Conference Presentation
|
|
njpet8
|
62 |
24K |
1 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
62
|
24K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Plans U.S. Registered Public Offering and Listing
|
|
njpet8
|
45 |
18K |
4 |
05/01/24 |
05/01/24 |
ASX - By Stock
|
45
|
18K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Q3 2023 Business Update to Accompany Quarterly Results
|
|
njpet8
|
138 |
52K |
0 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
138
|
52K
|
0
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
njpet8
|
1.0K |
463K |
0 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
1.0K
|
463K
|
0
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - General discussion
|
|
njpet8
|
362 |
128K |
1 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
362
|
128K
|
1
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
njpet8
|
1.0K |
463K |
2 |
07/09/23 |
07/09/23 |
ASX - By Stock
|
1.0K
|
463K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Eureka report
|
|
njpet8
|
56 |
19K |
1 |
30/08/23 |
30/08/23 |
ASX - By Stock
|
56
|
19K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Acquires Optimal Tracers
|
|
njpet8
|
64 |
23K |
2 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
64
|
23K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Acquires Optimal Tracers
|
|
njpet8
|
64 |
23K |
1 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
64
|
23K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: First Patient Dosed in Phase 3 Illuccix China Study
|
|
njpet8
|
13 |
4.0K |
1 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
13
|
4.0K
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q4 FY2023
|
|
njpet8
|
29 |
12K |
3 |
31/07/23 |
31/07/23 |
ASX - By Stock
|
29
|
12K
|
3
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
njpet8
|
1.0K |
463K |
4 |
30/07/23 |
30/07/23 |
ASX - By Stock
|
1.0K
|
463K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
12 month price targets
|
|
njpet8
|
29 |
13K |
3 |
25/07/23 |
25/07/23 |
ASX - By Stock
|
29
|
13K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
njpet8
|
2.5K |
1.1M |
8 |
23/07/23 |
23/07/23 |
ASX - By Stock
|
2.5K
|
1.1M
|
8
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
njpet8
|
2.5K |
1.1M |
8 |
23/07/23 |
23/07/23 |
ASX - By Stock
|
2.5K
|
1.1M
|
8
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Activities Report and Appendix 4C - June 2023 Quarter
|
|
njpet8
|
52 |
24K |
5 |
20/07/23 |
20/07/23 |
ASX - By Stock
|
52
|
24K
|
5
|
|
ASX - By Stock
|
4DX |
Re:
4DX Chart
|
|
njpet8
|
787 |
353K |
1 |
10/07/23 |
10/07/23 |
ASX - By Stock
|
787
|
353K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
I'm Curious .. Why are You Selling Telix
|
|
njpet8
|
8 |
3.9K |
0 |
08/07/23 |
08/07/23 |
ASX - By Stock
|
8
|
3.9K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
I'm Curious .. Why are You Selling Telix
|
|
njpet8
|
8 |
3.9K |
2 |
07/07/23 |
07/07/23 |
ASX - By Stock
|
8
|
3.9K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Urology Innovation Showcase
|
|
njpet8
|
58 |
22K |
1 |
23/06/23 |
23/06/23 |
ASX - By Stock
|
58
|
22K
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
njpet8
|
2.5K |
1.1M |
4 |
22/06/23 |
22/06/23 |
ASX - By Stock
|
2.5K
|
1.1M
|
4
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
njpet8
|
2.5K |
1.1M |
2 |
19/06/23 |
19/06/23 |
ASX - By Stock
|
2.5K
|
1.1M
|
2
|
|
ASX - By Stock
|
4DX |
Re:
4DX Chart
|
|
njpet8
|
787 |
353K |
0 |
15/06/23 |
15/06/23 |
ASX - By Stock
|
787
|
353K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
SP if both FDA approvals go through
|
|
njpet8
|
233 |
83K |
1 |
08/06/23 |
08/06/23 |
ASX - By Stock
|
233
|
83K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
SP if both FDA approvals go through
|
|
njpet8
|
233 |
83K |
3 |
08/06/23 |
08/06/23 |
ASX - By Stock
|
233
|
83K
|
3
|
|